StockNews.com began coverage on shares of La Jolla Pharmaceutical (NASDAQ:LJPC – Get Rating) in a research note issued to investors on Thursday. The firm set a “buy” rating on the biopharmaceutical company’s stock. Separately, Zacks Investment Research downgraded La Jolla Pharmaceutical from a “buy” rating to a “hold” rating in a report on Wednesday, January […]
La Jolla Pharmaceutical (NASDAQ:LJPC – Get Rating) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $4.29 and traded as high as $4.34. La Jolla Pharmaceutical shares last traded at $4.24, with a volume of 55,115 shares. Several analysts have issued reports on […]